NL8002271A - Werkwijze ter bereiding van isopropylaminopyrimidine- hydroxyderivaten. - Google Patents

Werkwijze ter bereiding van isopropylaminopyrimidine- hydroxyderivaten. Download PDF

Info

Publication number
NL8002271A
NL8002271A NL8002271A NL8002271A NL8002271A NL 8002271 A NL8002271 A NL 8002271A NL 8002271 A NL8002271 A NL 8002271A NL 8002271 A NL8002271 A NL 8002271A NL 8002271 A NL8002271 A NL 8002271A
Authority
NL
Netherlands
Prior art keywords
hydrogen atom
isopropylamino
isopropylaminopyrimidine
hydroxy derivatives
product
Prior art date
Application number
NL8002271A
Other languages
English (en)
Dutch (nl)
Original Assignee
Produits Chimiques Societe Ano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Produits Chimiques Societe Ano filed Critical Produits Chimiques Societe Ano
Publication of NL8002271A publication Critical patent/NL8002271A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
NL8002271A 1979-04-30 1980-04-18 Werkwijze ter bereiding van isopropylaminopyrimidine- hydroxyderivaten. NL8002271A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7914987 1979-04-30
GB7914987 1979-04-30

Publications (1)

Publication Number Publication Date
NL8002271A true NL8002271A (nl) 1980-11-03

Family

ID=10504858

Family Applications (2)

Application Number Title Priority Date Filing Date
NL8002271A NL8002271A (nl) 1979-04-30 1980-04-18 Werkwijze ter bereiding van isopropylaminopyrimidine- hydroxyderivaten.
NL8002272A NL8002272A (nl) 1979-04-30 1980-04-18 Werkwijze ter bereiding van isopropylaminopyrimidine- hydroxy-derivaten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL8002272A NL8002272A (nl) 1979-04-30 1980-04-18 Werkwijze ter bereiding van isopropylaminopyrimidine- hydroxy-derivaten.

Country Status (26)

Country Link
JP (2) JPS55145670A (es)
AR (2) AR222869A1 (es)
AT (2) AT380013B (es)
BE (2) BE882594A (es)
CH (2) CH645633A5 (es)
DK (2) DK183880A (es)
EG (2) EG14259A (es)
ES (2) ES8103061A1 (es)
FI (2) FI66358C (es)
FR (2) FR2455588A1 (es)
GB (2) GB2055801B (es)
HK (2) HK55583A (es)
IE (2) IE49591B1 (es)
IN (2) IN154067B (es)
IT (2) IT1141487B (es)
LU (2) LU82333A1 (es)
MA (1) MA18824A1 (es)
MX (2) MX6514E (es)
MY (2) MY8400204A (es)
NL (2) NL8002271A (es)
NO (2) NO154055C (es)
NZ (2) NZ193422A (es)
OA (2) OA06527A (es)
PT (2) PT71155A (es)
SG (2) SG22583G (es)
ZA (2) ZA801960B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63145595U (es) * 1987-03-13 1988-09-26
JPS645795U (es) * 1987-06-26 1989-01-13
JPH01100695U (es) * 1987-12-21 1989-07-06
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines

Also Published As

Publication number Publication date
FR2455589B1 (es) 1981-07-10
FR2455588A1 (fr) 1980-11-28
NZ193422A (en) 1981-12-15
NO154056C (no) 1986-07-09
IE800864L (en) 1980-10-30
PT71155A (en) 1980-05-01
AR222870A1 (es) 1981-06-30
IT8021543A0 (it) 1980-04-22
SG22583G (en) 1983-12-16
LU82332A1 (fr) 1980-07-02
NO154055B (no) 1986-04-01
GB2055801A (en) 1981-03-11
GB2054556B (en) 1983-01-26
ES491000A0 (es) 1981-02-16
EG14284A (en) 1983-09-30
IN154067B (es) 1984-09-15
ES490999A0 (es) 1981-02-16
ES8103060A1 (es) 1981-02-16
FI66358B (fi) 1984-06-29
JPS6116272B2 (es) 1986-04-28
NO154056B (no) 1986-04-01
JPS55145670A (en) 1980-11-13
ZA801960B (en) 1981-04-29
BE882593A (fr) 1980-07-31
NZ193421A (en) 1981-11-19
FI801083A (fi) 1980-10-31
IT1141487B (it) 1986-10-01
LU82333A1 (fr) 1980-07-02
AR222869A1 (es) 1981-06-30
OA06525A (fr) 1981-07-31
NO801235L (no) 1980-10-31
FR2455588B1 (es) 1983-04-15
MA18824A1 (fr) 1980-12-31
CH645633A5 (en) 1984-10-15
GB2055801B (en) 1983-02-09
NO801234L (no) 1980-10-31
MX5878E (es) 1984-08-16
OA06527A (fr) 1981-07-31
IN154066B (es) 1984-09-15
SG22283G (en) 1983-12-16
DK183880A (da) 1980-10-31
ATA221580A (de) 1985-08-15
IE49709B1 (en) 1985-11-27
CH645361A5 (en) 1984-09-28
AT380012B (de) 1986-03-25
FI801084A (fi) 1980-10-31
IE49591B1 (en) 1985-10-30
PT71154A (en) 1980-05-01
FR2455589A1 (fr) 1980-11-28
JPS55145671A (en) 1980-11-13
BE882594A (fr) 1980-07-31
NO154055C (no) 1986-07-09
NL8002272A (nl) 1980-11-03
EG14259A (en) 1983-09-30
IE800865L (en) 1980-10-30
ZA801958B (en) 1981-04-29
GB2054556A (en) 1981-02-18
DK183780A (da) 1980-10-31
FI66358C (fi) 1984-10-10
ATA221680A (de) 1985-08-15
FI66359B (fi) 1984-06-29
HK55683A (en) 1983-11-25
JPS6116273B2 (es) 1986-04-28
IT1141296B (it) 1986-10-01
MX6514E (es) 1985-06-26
AT380013B (de) 1986-03-25
ES8103061A1 (es) 1981-02-16
IT8021542A0 (it) 1980-04-22
FI66359C (fi) 1984-10-10
MY8400204A (en) 1984-12-31
HK55583A (en) 1983-11-25
MY8400203A (en) 1984-12-31

Similar Documents

Publication Publication Date Title
CH631696A5 (de) Verfahren zur herstellung von olefinischen derivaten von aminosaeuren.
JPS638378A (ja) ジベンゾチアゼピン化合物、その製造法、ならびに該化合物を含有する、抗精神作用および神経弛緩作用を有する製薬学的組成物
DE2607592A1 (de) Acetylenderivate von aminosaeuren sowie verfahren zu deren herstellung
JPS6126996B2 (es)
US11242340B2 (en) Crystal forms of demethyleneberberine hydrochloride and preparation method therefor
NL8002271A (nl) Werkwijze ter bereiding van isopropylaminopyrimidine- hydroxyderivaten.
JPH0526782B2 (es)
CA1064495A (en) Isopropylamino pyrimidine orthophosphate
DE2512609A1 (de) Pharmazeutische zubereitung
US3143469A (en) Anti-cholesterol nicotinic acid nu-oxide
US4416878A (en) [8-(Dialkylamino alkoxy)-caffeine]-platinum complex compounds and pharmaceutical products containing the same
CA1132562A (en) Halogeno derivatives of isopropylamino pyrimidine, their preparation and therapeutic use
EP0228314A2 (en) Use of ethanol/amine derivatives in treating or preventing hyperlipemia
CS207399B2 (en) Method of making the derivates of the benzodiazepine
JPS63135378A (ja) ブチロラクトン誘導体、その製造方法およびその用途
US3167476A (en) preparations acting on the central nervous
US2721203A (en) Chloral nicotinamide and method for preparing the same
US3824243A (en) Mono-o-phthalyl piperazine and mono-piperazine mono-phthalate di-salts
WO1992019597A1 (en) Gallic acid derivative, and pharmaceutical compositions containing it
KR840001708B1 (ko) 하이드록시 피리미딘 유도체의 제조방법
US3670083A (en) Germine-diacetate in the treatment of myasthenia gravis
KR810000382B1 (ko) 빈카민-5-피리독살포스페이트의 제법
JPWO2021080019A1 (ja) 新規有機ゲルマニウム化合物
RU2026070C1 (ru) 1-(гидроксиметил)-2-гидрокси-2-(4-нитрофенил)-этиламмоний 2-формилфеноксиацетат, обладающий антистрессорной активностью
DE2023974A1 (de) 2- (4 Aryl-l-piperazyl)-bicycloeckige Klammer auf 3,3,1 eckige Klammer zu -nonan-9-on-Derivate